Sana Biotechnology Director’s Quiet Buy‑Sell Dance Signals Both Hope and Risk in a Slumping Stock
Insider buying by Sana Biotechnology’s Wyrick Susan D. shows cautious optimism as the company’s shares decline, hinting at future upside from clinical data and product launches.
3 minutes to read